From the floor in Wuhan: 19 posters, one theme
Reported from the sessions, and from the two hours afterwards.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 112 of 170 of this archive, newest first.
Reported from the sessions, and from the two hours afterwards.
The document is four pages. Three of them are about dates.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Efficacy was never the question in this appraisal. Duration of treatment was.
A purity figure is silent on peptide content, on water, on counter-ion, on sterility, on endotoxin and on stability. Each of those silences has a price attached.
We separate what is supported, what is reasonable, and what is folklore, and we do not pretend the boundaries are crisp.
Efficacy was never the question in this appraisal. Duration of treatment was.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Efficacy was never the question in this appraisal. Duration of treatment was.
A monitoring schedule requires evidence about incidence. For this population, that evidence does not exist.
The Journal submitted split samples from single lots to three assay services, under names unconnected to this publication, and published each method alongside each result.
A flag is a probability statement about a population. It is not a statement about the person holding the printout.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The evidence base is thin and the document says so, which is to its credit.
The observation that closes a facility is rarely the dramatic one.
Three randomised withdrawal designs have tested what happens when treatment stops. Their results are consistent and they are consistently misreported.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The route did not close because of a rule about peptides.
A proper account of an operation that existed, and of what closing it cost.
The report states the gradient, the wavelength and the integration threshold, which is more than most.
We describe each pathway in enough chemical detail to explain why it is invisible to the method the trade uses, because that is the part which has practical consequences.
What the Journal would want measured before treating this as settled in either direction.
Aggregates dissociate in the mobile phase and are recorded as monomer. Only a size-based separation reports them.
Reported from the analysis, not from a warning notice.
Reported from the sessions, and from the two hours afterwards.
The evidence base is thin and the document says so, which is to its credit.
The result is unremarkable. What the report states alongside it is not.
A catalogue of open questions, with an assessment of how likely each is to be resolved.
Every third-party report in this market describes a sample somebody chose to send. That choice is outside the laboratory’s control and outside its records.